Clincosm LogoSign in Get a demo

How to Differentiate and Treat Cystic Laesions in the Anterior Mediastinum (DETECTION)

Sponsor
Maastricht University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05839678
Collaborator
Erasmus Medical Center (Other), The Netherlands Cancer Institute (Other)
200
Enrollment
1
Location
24
Anticipated Duration (Months)
8.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Multicenter trial about anterior mediastinal cysts

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    How to Differentiate and Treat Cystic Laesions in the Anterior Mediastinum (DETECTION)
    Actual Study Start Date :
    Dec 1, 2022
    Anticipated Primary Completion Date :
    Dec 1, 2024
    Anticipated Study Completion Date :
    Dec 1, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Percentage correctly diagnosed cystic laesions [2000-2022]

    Secondary Outcome Measures

    1. Patient characteristics, complications, comborbidities [2000-2022]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All

    Inclusion Criteria: cysts in the anterior mediastinum

    • Thymic cysts

    • Bronchogenic cysts

    • Pericardial cysts

    • Cystic thymoma

    • Cystic teratoma

    Exclusion Criteria:

    • Patients <18 years old

    • Patients without radiological imaging

    • Patients without approval for follow-up

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Maastricht UMC Maastricht Limburg Netherlands

    Sponsors and Collaborators

    • Maastricht University Medical Center
    • Erasmus Medical Center
    • The Netherlands Cancer Institute

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Florit Marcuse, MD, PhD, Maastricht University Medical Center
    ClinicalTrials.gov Identifier:
    NCT05839678
    Other Study ID Numbers:
    • 2022-3413
    First Posted:
    May 3, 2023
    Last Update Posted:
    May 3, 2023
    Last Verified:
    Apr 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of May 3, 2023